AURA BIOSCIENCES

aura-firma

First drug treatment for ocular melanoma

Aura is a company dedicated to developing an innovative therapy for the treatment of ocular melanoma as well as other eye cancers, based on a new viral nanoparticle technology that has the potential to target malignant cells without affecting healthy cells. This is potentially the first real alternative to current treatments for these cancers, which are highly invasive and often imprecise and toxic.

CEO: Elisabet de los Pinos.

INVESTED COMPANY
2016-2021 (IPO Nasdaq)

Details

Aura Biosciences, Inc.
85 Bolton Street

Cambridge, MA 02140, USA.

News